CARE Ratings
- Market cap
- ₹ 4,862 Cr.
- P/E
- 27.3x
- P/B
- 5.2x
- 52-week range
- 1,392.7 – 1,838
- ROE
- 20%
- ROCE
- 26%
- Dividend yield
- 1.4%
- Debt / equity
- 0.03
- Sector
- Capital Markets
- Industry
- Ratings
- Listed on
- NSE, BSE
About
CARE Ratings Limited is a credit rating company. The Company provides various credit ratings to corporates to raise capital for their various requirements and assists investors to form an informed investment decision based on credit risk and their own risk-return expectations. Its subsidiaries include CARE Ratings (Africa) Private Limited (CRAF), CARE Ratings Nepal Limited (CRNL), CARE ESG Ratings Limited, CARE Analytics and Advisory Private Limited, CARE Ratings South Africa (Pty) Limited and CareEdge Global IFSC Limited. CRNL offers a comprehensive array of rating services tailored to the Nepalese market, and technical support from its parent company. CareEdge Global IFSC Limited offers credit ratings and global-scale ratings for issuers and debt securities. CARE Analytics and Advisory Private Limited which specialises in the advisory, consulting, sustainability, research, and analytics services.
Quick check
The five things to look at first. Open one for more.
Latest announcements
Exchange filings and their impact on the company.
- CARE to sell 19.8% of its IFSC arm to SBI and NSE IFSC while retaining 80.2% control.
CARE Ratings has signed share purchase and shareholders agreements on October 19, 2026 to sell 9.9% each in its wholly owned subsidiary CareEdge Global IFSC Limited to State Bank of India and NSE IFSC Limited. After closing, CARE will hold 80.2% and CGIL will cease to be a wholly owned subsidiary but remain a subsidiary. Closing is expected within two months after closing actions and CGIL board approval for the transfer. The deal brings two strong strategic shareholders to the IFSC business while keeping control with CARE, with limited near-term financial impact.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 29 Oct 2026Upcoming | Financial Results/Dividend | To consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026 and consider declaration of Interim Dividend, if any, for the financial year 2026-27 |
| 7 Aug 2026 | Financial Results | CARE Ratings Limited has informed the Exchange about Board Meeting to be held on August 07, 2026 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 2026 |
| 13 May 2026 | Financial Results/Dividend | To consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the quarter and financial year ended on March 31, 2026 and to recommend Final Dividend, if any, for the financial year 2025-26 |
| 11 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 12 Nov 2025 | Financial Results/Dividend | To consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2025 and consider declaration of Interim Dividend, if any, for the financial year 2025-26. |
| 5 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 2 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and to recommend final dividend, if any |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 | 136 | 112 | 131 | 112 |
| Expenses | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 | 68 | 72 | 70 | 77 |
| Operating Profit | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 | 68 | 40 | 61 | 35 |
| OPM % | 43% | 30% | 32% | 28% | 47% | 32% | 43% | 30% | 50% | 36% | 46% | 31% |
| Other Income | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 | 13 | 13 | 16 | 15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 | 77 | 49 | 72 | 45 |
| Tax % | 29% | 30% | 32% | 30% | 27% | 27% | 26% | 29% | 26% | 25% | 26% | 27% |
| Net Profit | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 | 57 | 37 | 53 | 33 |
| EPS in Rs | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.24 | 8.61 | 18.89 | 11.96 | 17.58 | 10.73 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 5%
- 5 Years
- 14%
- 3 Years
- 19%
- TTM
- 18%
- 10 Years
- 4%
- 5 Years
- 14%
- 3 Years
- 27%
- TTM
- 25%
- 10 Years
- 4%
- 5 Years
- 21%
- 3 Years
- 29%
- TTM
- —
- 10 Years
- 19%
- 5 Years
- 16%
- 3 Years
- 18%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| CARE Ratings | ₹ 1,612.70 | ₹ 4,862 Cr. | 27.3x | 5.2x | 20% | — |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 226x | 3.8x | 1.6% | 1.5% |
| Urban Company | ₹ 132.65 | ₹ 20,457 Cr. | — | 8.9x | −11.9% | −15.1% |
| Indegene | ₹ 570.00 | ₹ 13,763 Cr. | 29.5x | 3.9x | 13.9% | 11.4% |
| BLS International Services | ₹ 208.70 | ₹ 8,593 Cr. | 14.2x | 3.9x | 32.7% | 24.1% |
| Axiscades Technologies | ₹ 1,915.00 | ₹ 8,154 Cr. | 83.3x | 9.1x | 10.5% | 6.2% |
Management
- Mehul Harshadray Pandya
- Group Chief Executive Officer, Managing Director, Executive Director
- Jinesh Shah
- Group Chief Financial Officer
- Manoj Kumar C.V
- Company Secretary, Compliance Officer
- Sanjay Agarwal
- Chief Risk Officer
Prices are delayed and for information only. Nothing on this page is investment advice.